List of works - Nesrina Imami

A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection

scientific article

A case of multidrug resistant primary HIV infection with delayed CD4 T-cell count decline despite low viral load, treated with interleukin-2

article

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses

scientific article published on 22 September 2011

A novel adhesion molecule in the murine thymic microenvironment: functional and biochemical analysis.

scientific article published on January 1992

A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy

scientific article published on 11 April 2007

A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy

scientific article published in December 2003

A point mutation in CD45 may be associated with an increased risk of HIV-1 infection

scientific article published on 01 September 2001

Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function.

scientific article published in November 2011

An anniversary without celebration?

scientific article published on 01 September 2006

Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals.

scientific article published on April 1996

Antigen presentation by interferon-γ-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells

scientific article published on 01 January 1997

Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010

scientific article

Assessment of Type 1 and Type 2 Cytokines in HIV Type 1-Infected Individuals: Impact of Highly Active Antiretroviral Therapy

article

Both age and gender affect thymic output: more recent thymic migrants in females than males as they age

scientific article published on 01 September 2001

CCR2/64I mutation detection in a HIV-1-positive patient with slow CD4 T-cell decline and delay in disease progression

article

Candidate vaccines for immunotherapy in HIV.

scientific article

Changes in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune Activation

scientific article published on 15 September 2017

Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipients.

scientific article

Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals

scientific article

Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma

article

Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.

scientific article published on 31 October 2008

Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy

scientific article published on 01 February 2004

EnhancedIn VivoImmunogenicity Induced by an Antibody to the IL-4 Receptor-Associated gp200-MR6 Molecule

scientific article published on 01 August 1996

Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection.

scientific article

Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients

scientific article published on 01 June 2007

Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjects.

scientific article

HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans

scientific article published on January 2004

HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans

scientific article published on July 2004

HIV-1 clade A infection and viral control: an immunological perspective on a case of underquantification

scientific article published on 01 November 2011

Human labour is associated with altered regulatory T cell function and maternal immune activation

scientific article published on 03 November 2019

Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active an

scientific article published on March 2002

Immune modulation and reconstitution of HIV-1-specific responses: novel approaches and strategies.

scientific article published on January 2006

Immune reconstitution in HIV-1-infected patients.

scientific article

Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination

article

Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infection.

scientific article published in November 2005

Immunomodulation in HIV-1 infection in the HAART era.

scientific article

Improving HIV-specific immune responses in HIV-infected patients.

scientific article

Increased serum transforming growth factor-beta1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration

scientific article published on 01 November 2003

Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy

article

Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection

scientific article published on 04 September 2020

Inhibition of alloreactivity by mAb MR6: differential effects on IL-2- and IL-4-producing human T cells

scientific article published on 01 October 1994

Initiation of Antiretroviral Therapy During Recent HIV-1 Infection Results in Lower Residual Viral Reservoirs

article

LACK OF T CELL PROLIFERATION WITHOUT INDUCTION OF NONRESPONSIVENESS AFTER ANTIGEN PRESENTATION BY ENDOTHELIAL CELLS1

scientific article published on 01 July 1999

Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization.

scientific article published on 14 April 2008

Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease

scientific article published on 17 August 2000

Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone

article

Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapy ⬇️

scientific article published in September 2013

Mechanisms of loss of HIV-1-specific T-cell responses.

scientific article

Molecular quantitation of thymic output in mice and the effect of IL-7.

scientific article published in October 2002

Multifarious immunotherapeutic approaches to cure HIV-1 infection

scientific article published on 5 June 2015

Novel approach to recognition of predicted HIV-1 Gag B⁎3501-restricted CD8 T-cell epitopes by HLA-B⁎3501+ patients: Confirmation by quantitative ELISpot analyses and characterisation using multimers

article

Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination.

scientific article published in March 2007

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda.

scientific article

Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection

scientific article

Pregnancy Gestation Impacts on HIV-1-Specific Granzyme B Response and Central Memory CD4 T Cells

scientific article published on 11 February 2020

Pregnancy-related immune suppression leads to altered influenza vaccine recall responses

scientific article published on 27 August 2019

Progesterone-Related Immune Modulation of Pregnancy and Labor

scientific article published on 29 March 2019

Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals

scientific article published in July 2009

Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study.

scientific article published on 7 April 2017

Prospects for immune reconstitution in HIV-1 infection

scientific article

ROLE OF THE THYMUS IN T LYMPHOCYTE RECONSTITUTION

scientific article published on 01 June 2000

Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: Concomitant assessment of perforin, IFN-γ and IL-4 secretion

article

Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials

scientific article published on April 2007

Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness

article

Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy

article

Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy

scientific article published in June 2003

Short Communication: Therapeutic Immunization Benefits Mucosal-Associated Invariant T Cell Recovery in Contrast to Interleukin-2, Granulocyte-Macrophage Colony-Stimulating Factor, and Recombinant Human Growth Hormone Addition in HIV-1+ Treated Patie

scientific article published on 05 February 2019

Single-Nucleotide Polymorphism–Defined Class I and Class III Major Histocompatibility Complex Genetic Subregions Contribute to Natural Long-term Nonprogression in HIV Infection

article

Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccine.

scientific article published on January 2007

Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy

article

T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness

scientific article

Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responses

scientific article published in November 2004

The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans.

scientific article

The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family

scientific article

The importance of standardisation of laboratory evaluations in HIV vaccine trials.

scientific article

Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection

scientific article published on 22 October 2014

Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease.

scientific article published in January 2007

Thymic Output during Initial Highly Active Antiretroviral Therapy (HAART) and during HAART Supplementation with Interleukin 2 and/or with HIV Type 1 Immunogen (Remune)

article

Thymic activity in late-stage HIV-1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapy

scientific article

Timing of antiretroviral therapy: an immunological perspective.

scientific article

Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus.

scientific article published on November 2008

Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllers

scientific article

Treatment of primary HIV-1 infection with nonnucleoside reverse transcriptase inhibitor-based therapy is effective and well tolerated

scientific article

Twenty years of HIV-1 research: what the future holds

article

List of works by Nesrina Imami

A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection

A case of multidrug resistant primary HIV infection with delayed CD4 T-cell count decline despite low viral load, treated with interleukin-2

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses

A novel adhesion molecule in the murine thymic microenvironment: functional and biochemical analysis.

A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy

A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy

A point mutation in CD45 may be associated with an increased risk of HIV-1 infection

Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function.

An anniversary without celebration?

Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals.

Antigen presentation by interferon-γ-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells

Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010

Assessment of Type 1 and Type 2 Cytokines in HIV Type 1-Infected Individuals: Impact of Highly Active Antiretroviral Therapy

Both age and gender affect thymic output: more recent thymic migrants in females than males as they age

CCR2/64I mutation detection in a HIV-1-positive patient with slow CD4 T-cell decline and delay in disease progression

Candidate vaccines for immunotherapy in HIV.

Changes in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune Activation

Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipients.

Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals

Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma

Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.

Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy

EnhancedIn VivoImmunogenicity Induced by an Antibody to the IL-4 Receptor-Associated gp200-MR6 Molecule

Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection.

Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients

Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjects.

HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans

HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans

HIV-1 clade A infection and viral control: an immunological perspective on a case of underquantification

Human labour is associated with altered regulatory T cell function and maternal immune activation

Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active an

Immune modulation and reconstitution of HIV-1-specific responses: novel approaches and strategies.

Immune reconstitution in HIV-1-infected patients.

Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination

Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infection.

Immunomodulation in HIV-1 infection in the HAART era.

Improving HIV-specific immune responses in HIV-infected patients.

Increased serum transforming growth factor-beta1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration

Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy

Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection

Inhibition of alloreactivity by mAb MR6: differential effects on IL-2- and IL-4-producing human T cells

Initiation of Antiretroviral Therapy During Recent HIV-1 Infection Results in Lower Residual Viral Reservoirs

LACK OF T CELL PROLIFERATION WITHOUT INDUCTION OF NONRESPONSIVENESS AFTER ANTIGEN PRESENTATION BY ENDOTHELIAL CELLS1

Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization.

Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease

Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone

Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapy ⬇️

Mechanisms of loss of HIV-1-specific T-cell responses.

Molecular quantitation of thymic output in mice and the effect of IL-7.

Multifarious immunotherapeutic approaches to cure HIV-1 infection

Novel approach to recognition of predicted HIV-1 Gag B⁎3501-restricted CD8 T-cell epitopes by HLA-B⁎3501+ patients: Confirmation by quantitative ELISpot analyses and characterisation using multimers

Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination.

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda.

Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection

Pregnancy Gestation Impacts on HIV-1-Specific Granzyme B Response and Central Memory CD4 T Cells

Pregnancy-related immune suppression leads to altered influenza vaccine recall responses

Progesterone-Related Immune Modulation of Pregnancy and Labor

Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals

Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study.

Prospects for immune reconstitution in HIV-1 infection

ROLE OF THE THYMUS IN T LYMPHOCYTE RECONSTITUTION

Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: Concomitant assessment of perforin, IFN-γ and IL-4 secretion

Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials

Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness

Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy

Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy

Short Communication: Therapeutic Immunization Benefits Mucosal-Associated Invariant T Cell Recovery in Contrast to Interleukin-2, Granulocyte-Macrophage Colony-Stimulating Factor, and Recombinant Human Growth Hormone Addition in HIV-1+ Treated Patie

Single-Nucleotide Polymorphism–Defined Class I and Class III Major Histocompatibility Complex Genetic Subregions Contribute to Natural Long-term Nonprogression in HIV Infection

Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccine.

Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy

T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness

Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responses

The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans.

The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family

The importance of standardisation of laboratory evaluations in HIV vaccine trials.

Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection

Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease.

Thymic Output during Initial Highly Active Antiretroviral Therapy (HAART) and during HAART Supplementation with Interleukin 2 and/or with HIV Type 1 Immunogen (Remune)

Thymic activity in late-stage HIV-1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapy